Discontinued — last reported Q3 '23
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)
Humana AFS and Trading Securities - Unrealized Loss Position (>=12 Months) decreased by 11.2% to $7.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.7%, from $8.79B to $7.76B. Over 3 years (FY 2022 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) shows relatively stable performance with a -0.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Higher values suggest a significant portion of the portfolio is subject to prolonged market value depreciation.
Detailed definition
The aggregate fair value of available-for-sale and trading debt securities that have been in an unrealized loss position...
Peer comparison
Standard metric for assessing long-term investment portfolio health across the banking sector.
afs_debt_securities_unrealized_loss_12m_plusHistorical Data
| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.96B | $9.08B | $9.98B | $11.05B | $10.56B | $11.21B | $9.84B | $9.10B | $8.79B | $8.37B | $8.76B | $8.74B | $7.76B |
| QoQ Change | — | +1.3% | +9.9% | +10.7% | -4.4% | +6.1% | -12.2% | -7.4% | -3.5% | -4.8% | +4.7% | -0.3% | -11.2% |
| YoY Change | — | — | — | +23.3% | +16.3% | +12.3% | — | -17.6% | -16.8% | -25.4% | -10.9% | -4.0% | -11.7% |
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) at Other Companies
Frequently Asked Questions
- What is Humana's afs and trading securities - unrealized loss position (>=12 months)?
- Humana (HUM) reported afs and trading securities - unrealized loss position (>=12 months) of $7.76B in Q1 2026.
- How has Humana's afs and trading securities - unrealized loss position (>=12 months) changed year-over-year?
- Humana's afs and trading securities - unrealized loss position (>=12 months) decreased by 11.7% year-over-year, from $8.79B to $7.76B.
- What is the long-term trend for Humana's afs and trading securities - unrealized loss position (>=12 months)?
- Over 3 years (2022 to 2025), Humana's afs and trading securities - unrealized loss position (>=12 months) has grown at a -0.8% compound annual growth rate (CAGR), from $8.96B to $8.74B.
- What does afs and trading securities - unrealized loss position (>=12 months) mean?
- The current market value of investment securities that have been worth less than their cost for over a year.